Recalled knee revisions cloud Smith & Nephew bright first quarter
This article was originally published in Clinica
An increase in the number of patients who required revision surgery after receiving Smith & Nephew cement-free knee implants which were withdrawn last August provided the one cause for concern in an otherwise positive first quarter for the UK company, which has just reported underlying sales growth of 12% (+9% reported) to £302m ($540m).
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.